| __timestamp | Amphastar Pharmaceuticals, Inc. | Blueprint Medicines Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 31844000 |
| Thursday, January 1, 2015 | 37065000 | 48588000 |
| Friday, January 1, 2016 | 41199000 | 81131000 |
| Sunday, January 1, 2017 | 43415000 | 144687000 |
| Monday, January 1, 2018 | 57564000 | 243621000 |
| Tuesday, January 1, 2019 | 68853000 | 331450000 |
| Wednesday, January 1, 2020 | 67229000 | 326860000 |
| Friday, January 1, 2021 | 60932000 | 601033000 |
| Saturday, January 1, 2022 | 74771000 | 477419000 |
| Sunday, January 1, 2023 | 73741000 | 427720000 |
| Monday, January 1, 2024 | 341433000 |
Data in motion
In the ever-evolving landscape of biopharmaceuticals, research and development (R&D) investments are pivotal. Over the past decade, Blueprint Medicines Corporation and Amphastar Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D expenditures. From 2014 to 2023, Blueprint Medicines has consistently outpaced Amphastar, with its R&D spending peaking at over 600% higher than Amphastar's in 2021. This trend underscores Blueprint's aggressive pursuit of innovation, particularly in precision therapies for genomically defined cancers. Meanwhile, Amphastar's steady increase in R&D, with a 160% rise from 2014 to 2023, reflects its commitment to enhancing its portfolio of generic and specialty pharmaceuticals. As the industry continues to prioritize groundbreaking treatments, these investments highlight the strategic priorities of each company, shaping the future of healthcare innovation.
Pfizer Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Viatris Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Blueprint Medicines Corporation
Blueprint Medicines Corporation or Grifols, S.A.: Who Invests More in Innovation?
Blueprint Medicines Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Blueprint Medicines Corporation vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development Investment: Blueprint Medicines Corporation vs Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ultragenyx Pharmaceutical Inc. and Amphastar Pharmaceuticals, Inc.
R&D Spending Showdown: Veracyte, Inc. vs Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Xenon Pharmaceuticals Inc. vs Amphastar Pharmaceuticals, Inc.
Comparing Innovation Spending: Wave Life Sciences Ltd. and Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Amphastar Pharmaceuticals, Inc. vs Novavax, Inc.